Valeant Pharmaceuticals International Inc (VRX)

15.77
0.27 1.70
NYSE : Health Care
Prev Close 15.50
Open 15.35
Day Low/High 14.89 / 15.85
52 Wk Low/High 8.31 / 32.74
Volume 37.73M
Avg Volume 21.14M
Exchange NYSE
Shares Outstanding 347.91M
Market Cap 4.76B
EPS -6.90
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Dow and S&P 500 Rip Higher to New Records -- Thanks Apple and Amazon!

Dow and S&P 500 Rip Higher to New Records -- Thanks Apple and Amazon!

A tech recovery pushes the S&P 500 and Dow to records.

Dow and S&P 500 on Track for Records as Apple Drives a Tech Recovery

Dow and S&P 500 on Track for Records as Apple Drives a Tech Recovery

Stocks move higher as tech sector names make gains.

Billionaire John Paulson Wants You to Buy Valeant -- Here's What the Chart Says

Billionaire John Paulson Wants You to Buy Valeant -- Here's What the Chart Says

The price action is pointing toward more upside in this beaten-down biotech stock.

Midday Report: Apple Leads Dow in Tech Recovery; Amazon at All-Time Highs

Midday Report: Apple Leads Dow in Tech Recovery; Amazon at All-Time Highs

The Dow Jones Industrial Average and S&P 500 reached new highs to begin the week as tech stocks resumed their recovery.

Apple Drives Dow to a New Record, Amazon at All-Time Highs

Apple Drives Dow to a New Record, Amazon at All-Time Highs

Stocks move higher as tech sector names make gains.

Stock Futures Point to a Higher Open for Wall Street, Dow Looks Set for a New Record

Stock Futures Point to a Higher Open for Wall Street, Dow Looks Set for a New Record

Futures move higher as tech sector makes gains.

Valeant Stock Jumps After John Paulson Named to Board

Valeant Stock Jumps After John Paulson Named to Board

Paulson is Valeant's largest shareholder.

Tech Stocks Just Blew Up -- Here Are 7 Things to Know From a Wild Week on Wall Street

Tech Stocks Just Blew Up -- Here Are 7 Things to Know From a Wild Week on Wall Street

Comey's testimony, elections in the U.K., London's terror attacks, what a week.

Comey's Hotly-Anticipated Testimony Sets Wall Street on Edge but Stocks Finish With Small Gains

Comey's Hotly-Anticipated Testimony Sets Wall Street on Edge but Stocks Finish With Small Gains

Former FBI Director James Comey gave public testimony to the Senate on President Donald Trump and possible connections with Russia. And markets were riveted.

Valeant's Latest Divestiture Seems to Please Investors But Its Massive Debt Still Hovers

Valeant's Latest Divestiture Seems to Please Investors But Its Massive Debt Still Hovers

Valeant is selling its Australian unit iNova to raise $930 million to pay down debt.

Stocks Deflate as Wall Street Digests Fallout of Comey Testimony

Stocks Deflate as Wall Street Digests Fallout of Comey Testimony

Stocks deflate from session highs on Thursday as Wall Street digests public testimony from former FBI Director James Comey.

Midday Report: Nordstrom Considers Going Private; Wall Street Watches Comey Hearing

Midday Report: Nordstrom Considers Going Private; Wall Street Watches Comey Hearing

Wall Street fluctuate as the country held riveted by former FBI director James Comey's public Senate testimony.

S&P 500 Hugs Flatline as Comey Talks Russia Interference, Discussions With Trump

S&P 500 Hugs Flatline as Comey Talks Russia Interference, Discussions With Trump

Stocks move back into the green on Thursday as former FBI director James Comey delivers public testimony before the Senate Intelligence Committee.

Valeant to Sell iNova Unit in Latest Bid to Pay Off Long-Term Debt

Valeant to Sell iNova Unit in Latest Bid to Pay Off Long-Term Debt

The unit has a strong presence in Australia, South Africa and Asia.

Stocks Set to Rise on a Super-Charged Thursday, ECB Holds Rates Steady, U.S. Jobless Claims Fall

Stocks Set to Rise on a Super-Charged Thursday, ECB Holds Rates Steady, U.S. Jobless Claims Fall

The wait is over. The potentially market-moving Thursday is here.

Citron Takes Aim at Mallinckrodt, Blasts Acthar Gel Medication

Citron Takes Aim at Mallinckrodt, Blasts Acthar Gel Medication

Citron attacked Mallinckrodt's partnership with Express Scripts ESRX, liking it to the role specialty prescription company Philidor played for embattled pharma company Valeant.

Fitting End to Weird Week

Buyers jump in after jobs report.

Behind the War Between Health Insurers and Pharmacy Benefit Managers

Behind the War Between Health Insurers and Pharmacy Benefit Managers

More competition could help overcome the suspicion over drug prices that plagues the would-be business partners' dealings.

Young Guns of Activism Join Boards at AIG, SunOpta and DepoMed

Young Guns of Activism Join Boards at AIG, SunOpta and DepoMed

A review of data produced by BoardEx reveals that many big and small activist-targeted corporate boards feature young directors in their early-to-mid 30s who work for insurgent fund managers

Bill Ackman Details Missteps With Valeant Investment

Bill Ackman Details Missteps With Valeant Investment

The embattled activist talked about his troubled investment in Valeant, his efforts at Chipotle and what he'd like to see the Trump Administration focus its energy on.

5 Things You Must Know Before the Market Opens Friday

5 Things You Must Know Before the Market Opens Friday

U.S. stock futures and global shares are higher as investors looked to recoup losses from a week that saw volatility rise amid turmoil in the Trump White House.